KPV

Description

TLDR: KPV is currently being investigated for anti-inflammatory properties and gut health related issues.

 

KPV (lysine–proline–valine) is a naturally derived synthetic tripeptide that has gained significant attention in preclinical research for its targeted anti-inflammatory and tissue-protective properties. Composed of just three amino acids, it forms the C-terminal sequence (positions 11–13) of the larger neuropeptide alpha-melanocyte-stimulating hormone ($\alpha$-MSH). While parent $\alpha$-MSH exerts broad anti-inflammatory effects by binding to melanocortin receptors, it also triggers skin pigmentation (melanogenesis) and appetite modulation. Isolating the terminal KPV fragment strips away these receptor-mediated side effects—allowing researchers to leverage its potent anti-inflammatory activity without causing tanning or major hormonal shifts.

At the cellular level, KPV operates via a unique intracellular mechanism rather than binding to cell-surface receptors. It is taken directly into cells by peptide transporter 1 (PepT1), an active transport channel found on mucosal, skin, and immune cells. Notably, PepT1 expression is significantly upregulated in inflamed tissues, enabling KPV to naturally accumulate at higher concentrations in damaged areas. Once inside the cell, KPV acts as a signal dampener by suppressing the nuclear factor kappa B (NF-$\kappa$B) and MAP kinase pathways—the main master switches responsible for transcribing pro-inflammatory cytokines such as TNF-$\alpha$, IL-1$\beta$, and IL-6. By turning off the cascade at its core, KPV reduces tissue edema and swelling without broad immune suppression.

These properties have driven investigation into KPV across several specific therapeutic areas:

• Intestinal Health & Inflammatory Bowel Disease (IBD): Animal models of colitis demonstrate that oral KPV significantly reduces colonic tissue damage, calms intestinal mucosal inflammation, and helps preserve mucosal barrier integrity.
• Dermatological Repair: In topical formulations, KPV is actively studied for accelerating wound closure, calming contact dermatitis, easing skin redness, and managing conditions like psoriasis or eczema.
• Systemic & Antimicrobial Applications: Preclinical studies explore injectable and oral formats to tackle systemic immune overactivation and mast cell reactivity, alongside observing mild innate antimicrobial activity against pathogens like Candida albicans and Staphylococcus aureus.

For in-vitro research and laboratory use only. Not intended for human or veterinary use. By purchasing, you confirm you are a qualified researcher and will use this compound in accordance with all applicable laws and regulations.